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Factors that might affect the fatty acid composition of serum cholesterol esters 
3) and ，2(1， Age(Ch. E.) in human beings have been studied by many researchers. 
dietary conditions (4， 5)have been known to show some effects on the fatty acid com-
posi tion of serum Ch.E. 
Studies have also been reported on the fatty acid composition of serum Ch.E. in 
patients with various diseases， such as diabetes mellitus (6， 7)， atherosclerosis (2， 3， 7)， 
idiopathic hypercholesterolemia (3) and nephrosis (7). It has been shown in these diseases 
that saturated and monounsaturated fatty acids are increased and polyunsaturated fatty 
acids are decreased in serum Ch.E. composition. High levels of serum total cholesterol 
(T.Ch.) were observed in these diseases， and the relationships between the fatty acid 
composition of Ch.E. and the level of T.Ch. in serum were discussed by Goodman (8). 
In hepatic parenchymal diseases， the levels of serum T.Ch. were known to have 
a tendency to decrease (9)， but the changes in fatty acid composition of serum Ch.E. 
were similar to those of hypercholesterolemic diseases (1 0， 1， 12， 13). Although the 
mechanismus of these changes were yet obscure， it is probable that the disturbances of 
the fatty acid and Ch.E. metabolism are concerned with these changes of fatty acid com・ 
position of serum Ch.E. in hepatic diseases. 
The studies described in this paper were undertaken to observe the changes in fatty 
acid composition of serum Ch.E. .in hepatic diseases in detail， and further to investigate 
certain aspects of serum Ch.E. metabolism in these pathological conditions. 
Mctericls 
Specimens were obtained from 35 hospitalized patients with various hepatic diseases 
and 14 healthy subjects as controls. 
Ten cases of acute hepatitis including 2 of fulminant hepatitis (No. 2 and No. 8 in 
Table 2) were ikteric. The patients were between 18 and 39 years old (average: 25.6 
yr.)， and 6 were male and 4 female (Table 2). 
All cases of chronic hepatitis were diagnosed by the findings of liver biopsy. The 
patients were from 30 to 62 years in age (average: 44.5 yr.)， and 3 of them were male 
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and 7 female. The cases from No. 1 to No. 7 in Table 3 were anicteric， but No. 8 to 
No. 10 were in the stadium of acute exacerbation of chronic hepatitis and were icteric 
(Table 3). 
The diagnosis of liver cirrhosis was also based on histological criteria. There were 
no cases of hepatic coma. The patients are between 41 and 60 years old (average: 51. 1 
yr.)， and 8 were male and 2 female (Table 4). 
Primary disorders of obstructive jaundice cited in Table 5 were choledochus stones 
(No・ 1and No. 2 in Table 5)， carcinomas of pancreas (No・ 3and N o.4 in Table 5)， and 
gastric carcinoma with hilus lymphnode metastasis (No. 5 in Tabe 5). None of them 
had any evidences of liver metastasis on abdominal surgery. The patients were from 
40 to 67 years old (average: 59.2 yr.)， and 4 were male and 1 female (Table 5). 
The healthy controls were from 18 to 30 years of age (average: 26.2 yr.) and 6 of 
them were male and 8 female (Table 1). 
All blood speciJ;l ens were obtained in early morning after over~night fasting. 
Analytical Methods 
Serum lipids were extracted with 20 volumes of chloroform~methanol (2/1， v/v) and 
washed with 0.2 volume of water (1 4). 
Serum lipid phosphorous was determined by the method of Allen (1 5)， trigly~ceride 
(T.G.) by the method of Van Handel~Zilversmit (1 6) and T.Ch. by the method of Zak 
(17). 
Method for the determination of cholesterol ester ratio (Ch.E.R.) was summarized in 
edand free cholesterol were separated by thin-layer chromatography 日The esteri1. Fig. 
and determined by the method of Zak. 1t was shown by Nichman et al that iodine 
vapor was reacted with unsaturated fatty acids of Ch.E. on thin~layer chromatoplate (1 8)， 
but in such conditions as described in Fig. 1， the Kiliani's reaction was not influenced 
by this identification procedure even using iodine vapor. Recoveries of cholesteryl 
palmitate and cholesterol were about 100%. 
The fatty acid composition of Ch.E. was analyzed by thin-layer chromatography and 
gas~liquid chromatography (Fig. 2). 1n our previous studies， N/5 methanolic KOH was 
used for alkaline hydrolysis of Ch.E. (1 9)， but with this low concentration of KOH，fatty 
becauseof partial ，・ablematerials五acids were lost during extraction procedure of unsaponi 
methanolysis of Ch.E. Therefore 1 N methanolic KOH was employed in this study. 
Recoveries of fatty acids of Ch.E. were over 90% in these conditions throughout this 
study. 
For the analysis of the fatty acid composition of the major lipid classes (Ch.E.， 
T.G.， FFA， and Ph.L.)， serum lipids were fractionated by two-step developement 
method of thin-layer chromatography (Fig. 3) in order to obtain optimum separation of 
Ch.E. from solvent front and T.G. from FF A. Recoveries of each lipid fraction from 
chromatoplate were over 95%. 
Lineality response of instrument was examined by qualitative fatty acid mixture 
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1.Fig. Method for determination of cholesterol ester ratio using 
thin-layer chromatography. 
Extraction of serum lipids 
(削)1. 1Folch et a
Thin-layer chromatography 
plate : 0.5 mm，Silica gel G. (Merck，Germany). 
developing solvent: 
1.90/10/，petroleum etherjdiethyl ether/acetic acid↓ 
Iden tifica tion 
iodine vapor. 
spots of cholesterol and cholesterol esters were marked. 
Recovery 
after evaporating of iodine，each spot was scraped into test tube. 
six ml of 4 x10-4M FeC13 in acetic acid were added，the test tube was mixed 
and the mixture was filtrated. 
Deterrilination 
3 ml of filtrate十2ml of conc. H 2S04・ 
after mixing and standing for 30 min. optical density was determined at 570 mμ. 
Calculation 
0. D. of cholesterol esters 
. D. of cholesterol esters +O. D. of free cholester ，-x 100 =cholesterol ester ratio (%). 
Fig. 2. Method for determination of fatty acid composition 
of cholesterol esters. 
Extraction of serum lipids 
|…:3 to 5 ml 
↓ Folch et al.(1957) 
Preparative thin-layer chromatography 
ck，G…り)dyI pμ凶向伽加愉旬la剖仰引: 0.5mmい，SillCαagel日 れ叩川G 附te 白吋ev 
↓ p廿 叩umether/diethy1ether，95/5.戸etrole 児 げ 出刊 
Identification 
under ultraviolet lamp， 
spot of cholesterol esters was marked. ↓ 
Recovery 
l spot was sc叩 donto伽 r仰 er，and c仙 sterolesters were eluted with 40 
↓ ml of chloroform/methanol，2/1. 
Alkaline hydrolysis 
with 10 ml of 1 N methanolic KOH. 
↓ at 70
oC，for 1 hr. 
Methylation 
at1000C for 3 min 山仇BFm開mlof:山I 
(1961) 1.Metcalfe et a↓ ・ 
Gaschromatography 
Hitachi KGL 2 A (FID) 
20% ethylene g1ycol succinate polyester 
(80 to 100 mesh Diasolid) 
carrier gas: He，ca. 60 ml/min.，at 1950C. 
- -
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Method for determination of fatty acid composition of various 
serum lipid fractions 
x& 目官 心 4 a t w  ri 'EEA AUAr a l l - - - +c on o QO e r u m P
M
。 、  ， .  
ふ 
serum 5 m1 or more. 
Fo1ch et al. (1957) 
Preparative thin-1a yer chroma togra ph y 

p1ate: 0.5 mm Silica gel G. (Merck Germany). 

deve1opment: two step development. 

1. petro1eum ether/diethy1 ether/acetic acid，100/30/2，7 cm. 
cm.14，90/10/1，petro1eum ether/diethy1 ether/acetic acid2. 
Identification 
0.005% Rhodamin 6 G inmethanol. 
the origin (Ph. L.) was protected from the spray. 
Recovery 
each spot was scraped into centrifuge tube and e1uted three times with 20 m1 
of following solvent， 
Ph. L.: chloroform/methanol/acetic acid/water，25/10/3/2. 
↓ neutra1 1ipid fractions: diethyl ether. 

A1kaline hydrolysis 

l W i 山 Of ωha仙仇叩 n パ川a抗th10 ml oハ1N met 山 KOH，剖t初ぱ山 刷a
↓ Ph. L.: for 3 hr.，neutral lipid fractions: for t hr. 
Methylation 

i with 10mlof13%BFm山仇 at100oC，for 3 min 

↓ Metcalfe et al. (1961) 

Gaschromatography 

(Applied Science，U.S.A.)，and each fatty acid was identified by relative retention time 
of standard fatty acid. Areas on gaschromatogram were calculated from peak hight and 
half width. 
Results 
Fatty acid composition of serum Ch.E. and 1ipid 1eve1s in healthy subjects 1. 
(Tab1e 1). 
1 % 1.%) and 5.1The fatty acid composition of serum Ch.E. were mostly unsaturated (84 
of them was lino1eic acid. Among saturated fatty acids，pa1mitic acid was a major com-
ponent (13.6%). No significant difference between male and femal was found. 
Although relatively large individua1 variations and sex differences were observed in 
serum T.Ch. 1evels，but Ch.E.R. was similar through these healthy young controls (75.8 
土 2.3%). 
2. Changes in fatty acid composition of serum Ch.E. and in lipid levels of patients 
with acute hepatitis (Tab1e 2). 
In acute hepatitis，the marked changes were observed in the fatty acid composition 
of serum Ch.E. Decrease of the percentage of 1ino1eic acid was most predominant (37J 
土 6.8%). The decreased percentage of arachidonic acid was also observed，but its changes 
30 OKAZAKI 
Table 1. Serum lipids in healthy subjects 
Chole-
Total Total sterol 
Case phosph- Trigly-chole- ester Fatt)' acid composit~oIl_ o[ c_h?!es!er_o! _es_ter:_s 
No. Age Sex -oliplds ceride sterol ratio C 14: 0 C 16: 0 C 16: 1 C 18: 0 C 18: 1 C 18: 2 C20: 4 
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Table 2. Serum lipids in acute hepatitis 
Chole-
Total Total sterol 
Case phosph- Trigly-chole- ester Fatty acid composition of cholesterol esters 
No. Age Sex olipids ceride sterol ratlO C 14 : 0 C 16: 0 C 16: 1 C 18: 0 C 18: 1 C 18: 2 C 20: 4 
mg/dl mg/dl mg/dl % % 
161 108 180 63.9 0.6 17.0 8.2 1. 7 22.6 44.3 5.6 
27.2 29.7 7.6
2345678
戸 
0 3
ヮ “
qLtioooany FFFFMMMM
TAQJqdqJ'11A
3nynO 
106 95 85 43.7 2.7 18.3 6.9 7.6 
203 149 182 72.6 1.9 18.1 12.6 2.0 26.0 34.6 4.8 
260 212 254 47.4 1.0 15.4 12.3 0.9 24.6 42.3 3.5 
176 168 130 38.0 1.0 17.5 7.3 1. 9 23.2 42.9 6.2 
289 188 106 39.0 0.9 17.1 7.3 3.2 26.9 39.3 4.9 
180 151 160 30.7 1. 5 21.2 11.8 3.8 24.6 30.5 6.6 
126 97 127 54.4 2.3 23.0 9.8 5.0 27.5 29.1 3.3 
9 21 M 207 275 164 62.2 1. 2 15.6 5.9 2.5 22.4 46.4 6.0 
10 20 M 118 235 107 39.1 1. 8 18.8 12‘5 2.6 28.2 31. 1 5.0 
円 :・伺MS o oFM
±D
勢 P < 0.01，柿 Pく 0.05 
were small and not significant. Remarkable increases were seen in the percentage of 
palmitic， palmitoleic，stearic and oleic acids. In consequence of these changes， unsaturated 
fatty acids decreased to 77.2%. Decrease of the percentage of linoleic acid was found 
the most in the cases of fulminant hepatitis (No. 2 and No. 8 in Table 2). In addition， 
'EA
168 150 .1 49 1. 5 18.2 9.5 3.1 25.3 37.1 5.4 
」」ハ↓ 戸  
士土土 土士土:t :t土土 
60勢 46帯恭 13.6長 0.7 2.4勢 2.6勢 1.9勢各 2.1恭 6.8勢 l.lL O  U 
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these changes in fulminant hepatitis were associated with decreases of serum Ch.E.R. 
The serum Ch.E.R. decreased in almost al cases of acute hepatitis. Average level 
of serum T.Ch. was normal， but apt to decrease. The increased levels of serum T.G. 
and Ph.L. were usually found in acute hepatitis， but decreases of al lipid levels were 
pointed out in fulminant hepatitis. 
3. Changes in fatty acid composition of serum Ch.E. and in lipid levels of patients 
with chronic hepatitis (Table 3). 
Changes in fatty acid composition of serum Ch.E. were minor but similar to the 
changes in acute hepatitis. The decreased percentage of linoleic acid， the increased 
percentages of palmitic， palmitoleic and oleic acids were significant. The total percentage 
of unsaturated fatty acid was 80.4%. 
The levels of serum Ph.L.， T.G. and T.Ch. were usually high in chronic hepatitis. 
The average value of Ch.E.R. decreased slightly， but in anicteric and static cases， ifnot 
icteric (No. 8， 9 and 10 in Table 3)， the values were within normal limit. 
and in lipid levels of patients E.Changes in fatty acid composition of serum Ch.4. 
with liver cirrhosis (Table 4). 
Changes in fatty acid composition of serum Ch.E. was relatively large but smaller 
than acute hepatitis， and .larger than chronic hepatitis. The percentage of linoleic and 
arachidonic acid decreased significantly. And conspicuous increases were found in the 
percentage of palmitic， palmitoleic and oleic acid. The total percentage of unsaturated 
fatty acid was 78.5%. The changes of fatty acid composition of serum Ch.E. were not 
always acompanied by the changes of serum lipid levels in liver cirrhosis. 
The levels of serum lipid were low. Significant decreases were found only in Ch.E.R.， 
the average levels of T.G.， Ph.L. and T.Ch. were in normal range. But in comparison 
Serum lipids in chronic hepatitis 3. Table 
Ohole-
Total Total sterol 
Case phospidhs・ FattyTri事ldly-chole-ester C acid com16p:ol sition of cholesterol esters 
No. Age Sex olipids ceride sterol ratio 014:0 016:0 016:1018:0 018:1018:2 020:4 
60 M mg16/5dl .3mg10/d3l m1g22/d17936 0.8 17.9 .18 %2.5 25.9 40.5 4.3 
2 30 五，1 193 183 212 71. 3 2.0 16.5 .16 1. 6 24.1 40.9 6.1 
3 37 M 268 162 385 70.3 0.7 15.6 .110 1. 4 31. 8 35.2 5.2 
4 53 F 153 113 138 77.0 0.4 17.2 5.7 2.4 26.7 38.1 9.5 
5 47 F 195 11 215 72.3 1. 6 17.6 .19 1. 4 24.4 39.4 6.5 
6 53 F 266 143 248 74.7 0.9 14.5 6.0 1. 4 22.2 48.3 5.2 
7 38 F 165 78 165 73.7 1.1 16.7 7.2 1.1 24.5 38.6 7.4 
8 30 F 275 109 386 63.7 0.7 14.5 9.8 .12 28.6 39.7 5.4 
9 62 F 243 143 280 57.0 0.2 13.7 5.3 1. 2 19.6 55.3 4.6 
10 35 F 225 264 264 58.3 1. 6 16.0 13.0 1. 2 23.9 37.1 5.2 
Mean 215 141 242 69.2 1. 0 16.0 8.0 1. 6 25.3 41. 3 5.9 
士 士 士 士 士 土 士 士 土 土 士 士 
S.D. 47帯 53勢 92帯長 7.0帯 0.6 1. 4後 2.5恭 0.5 3.4骨骨 6.0桂長 1. 6 
長 Pく 0.01，州 Pく 0.05 
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Table 4. Serum lipids in liver cirrhosis 
Chole-
Total Total sterol 
Case pohl ospidhs .Tcrein写 dlye・ chole- ester Fatty om16p:ol sition of cholesterol esters C acid cC 
No. Age Sex olipids ceride sterol ratlO C 14 : 0 C 16: 0 C 16: 1 C 18: 1 C 18: 1 C 18: 2 C 20: 4 
43 M 
mg18/8dl m8g5/3dl m1g19/d16986 .3 l. 4 18.9 8.5 %1.9 25.4 41. 4 2.5 
2 60 M 175 90.6 185 68.2 l. 4 18.7 10.8 l. 9 29.4 30.9 4.2 
3 41 M 155 69.1 137 55.6 l. 0 17.0 8.1 l. 4 26.9 40.9 5.0 
4 42 M 128 44.9 93 66.5 0.9 18.3 8.3 2.0 27.6 40.2 2.8 
5 55 M 133 87.0 155 66.0 l. 7 17.8 10.9 2.5 25.4 39.5 2.2 
6 45 M 205 98.7 180 67.8 l. 1 18.0 8.5 2.1 26.6 39.2 4.5 
7 60 M 160 70.8 145 66.3 l. 6 19.2 6.8 0.8 27.9 38.2 6.0 
8 53 M 185 62.9 227 60.4 0.9 16.2 9.5 1. 9 25.9 42.5 3.1 
9 60 F 131 62.5 87 7l.l 1. 7 19.8 12.0 2.8 25.8 33.7 4.2 
10 52 F 177 107.7 277 64.2 1. 5 19.1 7.1 1. 6 24.1 4l. 2 5.4 
Mean 164 70.8 156 65.5 1. 3 18. 3 9.0 1. 9 26.5 38.8 4.0 
十 + ± 士 土 + 土 土 + + + 
S.D. 23 18.4 49 4.4後 0.3 1.1長 0.6 1. 5骨骨 3.7骨 1. 3骨骨1.8長
十
勢 Pく 0.01，州 Pく 0.05 
with chronic hepatitis， all serum lipid levels were rather low in liver cirrhosis. These 
differences should not be overlooked. 
5. Changes in fatty acid composition of serum Ch.E. and in lipid levels of patients 
with obstructive jaundice (Table 5). 
In fatty acid composition of serum Ch.E.， the decrease in percentage of linoleic acid 
and the increased percentage of palmitoleic acid were significant. Changes in palmitic， 
stearic， oleic and arachidonic acid were small. The total percentage of unsaturated fatty 
acid was 81. 9%. 
In obstructive jaundice， the changes in fatty acid composition of serum Ch.E. were 
the smallest among the investigated groups， but the changes of serum lipid levels were 
the most remarkable. Marked increases of serum T.G.， Ph.L. and T.Ch. were observed. 
Decreases of Ch.E.R. were also remarkable. 
Table 5. Serum lipids in obstructive jaundice 
Chole-

Total Total sterol 

ester Fatty
Cacid com16p:o1 sition of cholesterol esters 
No. Age Sex olipids ceride sterol ratlO C14:0 C16:0 C16: 1 C18:0 C18: 1 C18:2 C20:4 
Case pohliopsipdLs TcUergidlye -chole-
m1g1/53 mg3/16dl m5g8/5 dl d1 976 .3 %1.865 F 0.6 15.0 7.7 21. 3 46.2 3.4 
2 67 M 319 318 400 24.4 1. 6 14.8 7.0 3.1 23.4 40.7 9.4 
3 40 M 263 156 377 50.2 0.9 16.7 7.4 1.1 24.0 42.3 7.6 
4 70 M 285 134 330 28.4 0.7 14.3 5.8 1. 5 21. 7 51. 6 4. 
5 54 M 302 181 380 25.7 1. 5 14.7 14.7 1. 7 27.7 36.5 3.2 
Mean 
+ 
S.D. 
464 
± 
386勢 
221 
土 
89勢 
406 
+ 
105勢 
27.2 
+ 
15.3持 
1.1 
± 
0.5 
15.1 
+ 
0.9 
8.5 
土
3.5勢 
1. 9 
土
0.6 
23.6 
土 
2.5 
43.5 
± 
5.7勢持 
5.6 
土 
2.8 
持 Pく 0.01，持 Pく 0.05 
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6. Correlation between changes in fatty acid composition of serum Ch.E. and in 
liver function tests. 
As described above， itwas observed in liver diseases that serum Ch.E. were com-
posed of relatively more saturated and monounsaturated fatty acids， and relatively less 
polyunsaturated fatty acids than in healthy subjects，and these changes were predominant 
when severe parenchymal damage was present (acute hepatitis). Then， the relationships 
between fatty acid composition of Ch.E. and hepatic function tests were investigated. 
The percentage of linoleic acid in Ch.E. was compared with serum transaminase 
activity， bilirubin and various lipid levels in the same specimens， but none of them 
correlated with linoleic acid decrease. And also the change in Ch.E.R. was not always 
accompanied by decreased percentage of linoleic acid (r = 0.1303). 
7. Changes in fatty acid composition of various serum lipid fractions of patients 
with acute hepatitis and liver cirrhosis (Fig. 4). 
On three patients out of each group of acute hepatitis， liver cirrhosis and healthy 
controls respectively， the fatty acid composition of serum Ch.E.， T.G.， FFA and Ph.L. 
were analyzed. 
The changes in fatty acid composition of Ch.E. were similar to the cases which were 
already described. Serum Ch.E. were composed of relatively less linoleic acid，and more 
palmitic，palmitoleic and oleic acids in acute 
hepatitis and .liver cirrhosis. The similar 
% 
ι口 Cho1estero1 esters changes were observed in T.G.， Ph.L. and 
30 噌 also in FFA fractions，but changes in these 
20 fractions were smaller than in Ch.E. fraction. 
10 
Discussion 
40 
30 
The fatty acid composition of serum 
20 
Ch.E. was analyzed in patients with various 
10 
hepatic diseases. Decreases of the percentage 
FFA of linoleic and arachidonic acids， and in-
40 
creases of palmitic，palmitoleic， stearic and 
30 
20 oleic acids were commonly observed in these 
10 diseases. The similar changes were reported 
in hypercholesterolemic diseases such as dia-
Phospho1ipids betes mellitus (6，7)，atherosclerosis (2，3， 7)，
品。 
30 idiopathic hypercholesterolemia (3) and ne-
20 phrosis (7). It was pointed out that increase 
10 of the percentage of palmitoleic acid was 
Cl与 :0 c16:0 C16:1 c18:0 c18:工 c18:2 C20:4 
the most predominant and characteristic in 
Fig. 4. Fatty acid composition of serum 
hepatic diseases (13). In this study， the 
increased percentage of palmitoleic acid was lipid fractions in patients with 
hepatic diSeases observed in almost al cases of hepatic dis-
34 OKAZAKI 
eases，and besides the remarkable decreased percentage of linoleic acid and the increased 
percentage of oleic acid were also found. The most remarkable change among these 
three was decrease in the percentage of linoleic acid. 
In hepatobiliary diseases， serum Ch.E.R. is influenced by hepatic cell degeneration 
and cholestasis (20). However，in observing fatty acid composition of Ch.E.，decrease of 
the percentage of linoleic acid was the most predominant in acute hepatitis， especially 
fulminant hepatitis. In obstructive jaundice，this change was minimal. That is，linoleic 
acid was decreased in acute hepatitis the most，in liver cirrhosis the second， chronic 
hepatitis the third，obstructive jaundice the least. Similar change was reported on the 
composition of total fatty acid in plasma lipids (21). These results suggest that the 
changes in fatty acid composition of serum of serum Ch.E. might occur mainly as a result 
of hepatocellular damage. But further evidences were not available right now from this 
study，and the relationships between abnormalities of hepatic function tests and decrease 
of the percentage of linoleic acid were neither demonstrated. 
It is an interesting problem if the changes in fatty acid composition of serum Ch.E. 
are the results of disturbances of fatty acid metabolism in hepatic diseases or abnorma-
lities of serum Ch.E. metabolism itself. As described previnusously，the changes of fatty 
acid composition were observed not only in Ch.E. fraction，but slso in T.G. and Ph.L. 
fractions which originate from the liver under fasting state， and FFA fraction which 
originates from adipose tissue (Fig. 4). Therefore it is probable that there are the meta-
bolic abnormalities of fatty acid，and the fatty acid composition of serum Ch.E. may 
affect these disturbed fatty acid metabolism. • 
The reason why the changes in Ch.E. composition are the most predominant is not 
determined from this study. However，there are some evidences that the disturbances 
of Ch.E. metabolism are concerned. 
In fulminant hepatitis，marked decrease of serum Ch.E.R. was accompanied by decrease 
of the percentage of linoleic acid in fatty acid composition of Ch.E. "In hepatocellular 
diseases，average value in decrease of Ch.E.R. was also proportional to decrease of the 
percentage of linoleic acid. Therefore it seems that the factors maintaing esterification 
of serum cholesterol operate also on the fatty acid composition of serum Ch.E.， but the 
correlation coefficient between Ch.E.R. and the percentage of linoleic acid in Ch.E. was 
r= 0.1303 in this study. Because of variety of conditions (stage of disease， participation 
of cholestasis，nutritional conditions and etc.)， this correlation coe伍 cient seems not to 
rule out relationships between Ch.E.R. and Ch.E. composition. To discuss this problem 
from clinical stand-point，it is necessary to observe more in detail in large numbers of 
cases of the same clinical conditions. In experimental studies with acute carbon tetra-
chloride intoxicated rats，the Ch.E.R. was significantly correlated with the percentage of 
linoleic and arachidonic acids in Ch.E. (22). There are species differences in the meta-
bolism of plasma Ch.E. between men and in rats (8). These results from experiments 
in rats might not be directly applicable to men. Further studies on this problem are 
required. 
Previously，the liver was considered to be a major source of serum Ch.E. (23)，but 
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recently a transesterification reaction between the beta fatty acid of lecithin and cho-
lesterol in plasma was demonstrated and accounted for an additional source of serum 
Ch.E. (24). 
The participation to the serum Ch.E. level of each source is stil obscure， but there 
are some reports which seem to support the importance of this latter mechanismus. 
(1) The fatty acid composition of Ch.E. in liver and in plasma was different (25， 26). 
That is， serum Ch.E. were composed more unsaturated fatty acid than liver Ch.E. And 
the more marked difference was reported in Refsum's syndrome. Seventy-two % of liver 
Ch.E. were composed from 3， 7， 1， 15tetramethyl-hexadecanoic acid in this disease， but 
this branched fatty acid. was not observed in serum Ch.E. (27). (2) The liver cholesterol 
esterifying enzyme (fatty acyl CoA cholesterol transferase， Goodman) had a high specific 
activity for synthesis of cholesteryl oleate (28). On the other hand， the beta fatty acid 
of lecithin in serum， which was transfered to free cholesterol by lecithin回 cholesterolfatty 
acyl transferase (Glomset)， was composed from more unsaturated fatty acid (24). (3) 
Recently Glomset et al showed the evidence that Ch.E. in high density lipoprotein was 
formed largely by this trasesteri五 cationreaction from greater rate of this reaction and 
greater turn-over of Ch.K in high density lipoprotein than in other lipoproteins (29). 
It was reported already that the cholesterol esterifying activity in plasma decreased in 
hepatic diseases (30， 31). But， atpresent time， itis difficult to consider that the changes 
in fatty acid composition of Ch.E. are the result of this decreased enzyme activity. 
Because of the fatty acid composition of Ch.E. of each group of three lipoprotein fractions 
were similar， and high density lipoprotein was not rich in polyunsaturated fatty acid 
(32， 3). And fractional turnover rates of individual Ch.E. in plasma were not specific 
in polyunsaturated fatty acids (34， 26). 
Recently Nestel et al observed the similarity in fatty acid composition of Ch.E. in 
plasma and in liver supernatant fraction， and also in turnover rates of labeled Ch.E. 
From these observations， they considered the common site of origin for Ch.E. of plasma 
and liver supernatant fraction locating within the liver (26). 
Therefore more extensive studies for plasma Ch.E. metabolism is needed to resolve 
the possible mechanismus of changes in fatty acid composition of plasma Ch.E. in hepatic 
diseases. 
Summary 
The fatty acid composition of serum Ch.E. was analyzed in patients with acute 
hepatitis (1 0 cases)， chronic nepatitis (10 cases)， liver cirrhosis (1 0 cases)， obstructive 
jaundice (5 cases) and healthy controls (14 cases). 
The fatty acid composition of serum Ch.E. in young healthy subjects was follow-1. 
ing; C 14: 0 0.7 + 0.2， C 16: 0 13.6土1. 6， C 16: 1 4.4+ 1. 5， C 18: 0 1.6土 0.6，C 18: 1 21. 6+ 4.0， 
C 18: 2 51. 1土 6.0， and C 20 : 4 6.3 + 4.4. 
2. In hepatic diseases， serum Ch.E. were composed of significantly less C 18: 2 acid， 
and more C 16: 0， C 16: 1， C 18: 0 and C 18: 1 acid. C 20: 4 acid decreased only in the 
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cases of li ver cirrhosis. 
3. The decreases of C 18: 2 acid in these diseases were the most in acute hepatitis， 
the second in liver cirrhosis， the third in chronic hepatitis and the least in obstructive 
jaundice. 
4. These results might suggest that the changes in fatty acid composition of serum 
Ch.E. occur main1y as a result of hepatocellular damage， and the influence of cholestasis 
is small. 
The author is grateful to Prof. Dr. S. Miwa for his interest and suppor throughout 
the investigation. Thanks are also extended to Dr. Kotoda and E. Araki for helpful 
suggestion， and恥 1iss.M. Murakoshi for her expert technica1 assistance. 
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